Improved Provocative Test for the Embolization of Arteriovenous Malformations--technical Note
Overview
Neurosurgery
Affiliations
A modified provocative test to assess the safety of embolization of cerebral and spinal arteriovenous malformations is described. The modified test uses successive amobarbital and lidocaine injections to elicit any possible neurological deficit, both mixed with radiopaque material to visualize the distribution of the anesthetic in the vessels. The modified provocative test caused no false negative results in 11 patients tested, compared to six of 27 patients with the unmodified method.
Nagashima H, Hongo K, Kobayashi S, Takamae T, Okudera H, Koyama J Interv Neuroradiol. 2010; 10 Suppl 2:54-8.
PMID: 20587250 PMC: 3522222. DOI: 10.1177/15910199040100S211.
Neurobehavioral differences in superselective Wada testing with amobarbital versus lidocaine.
Fitzsimmons B, Marshall R, Pile-Spellman J, Lazar R AJNR Am J Neuroradiol. 2003; 24(7):1456-60.
PMID: 12917146 PMC: 7973696.